Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Other Accumulated Expenses (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Other Accumulated Expenses for 2 consecutive years, with $3.1 million as the latest value for Q2 2023.

  • On a quarterly basis, Other Accumulated Expenses rose 1611.17% to $3.1 million in Q2 2023 year-over-year; TTM through Jun 2023 was $3.1 million, a 1611.17% increase, with the full-year FY2022 number at $1.4 million, changed N/A from a year prior.
  • Other Accumulated Expenses was $3.1 million for Q2 2023 at LENZ Therapeutics, up from $1.4 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $3.1 million in Q2 2023 to a low of $179000.0 in Q2 2022.